Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Idursulfase

    Client Email Product

    Idursulfase

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    GLOBAL SALES INFORMATION

    MARKET PLACE

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    0

    US DMFs Filed

    US DMFs Filed

    0

    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    0

    API REF. PRICE (USD / KG)

    0

    API Market Place

    0

    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    1
    Europe

    Europe

    1
    Canada

    Canada

    1
    Australia

    Australia

    0

    South Africa

    South Africa

    1
    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    44.00

    Annual Reports

    615.00

    FDF Market Place

    2
    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    4
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    EMA Grants ODD to GC Pharma's Hunterase ICV, for Mucopolysaccharidosis Type II
    EMA Grants ODD to GC Pharma's Hunterase ICV, for Mucopolysaccharidosis Type II

    https://www.businesswire.com/news/home/20211101006010/en

    BUSINESSWIRE
    01 Nov 2021
    Share Share
    Clinigen K.K., GC Pharma sign pact to market Hunterase ICV
    Clinigen K.K., GC Pharma sign pact to market Hunterase ICV

    https://www.biospectrumasia.com/news/50/13183/clinigen-k-k-gc-pharma-sign-pact-to-market-hunterase-icv.html

    BIOSPECTRUMASIA
    04 Apr 2019
    Share Share
    Shire's Biological Idursulfase Receives Supplemental Approval in US
    Shire's Biological Idursulfase Receives Supplemental Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125151

    FDA
    22 Nov 2018
    Share Share
    List of centrally authorised products requiring a notification of a change for update of annexes
    List of centrally authorised products requiring a notification of a change for update of annexes

    https://www.ema.europa.eu/documents/regulatory-procedural-guideline/list-centrally-authorised-products-requiring-notification-change-update-annexes_en-0.pdf

    EMA
    12 Oct 2018
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search